{"id":"W4387445228","doi":"10.1186/s10194-023-01671-5","title":"European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate","year":2023,"lang":"en","type":"review","venue":"The Journal of Headache and Pain","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"H. Lundbeck A/S; Bundesministerium für Bildung und Forschung; Amgen; Pfizer; European Stroke Organisation; Teva Pharmaceutical Industries; AstraZeneca; Allergan; Charité – Universitätsmedizin Berlin; Eli Lilly and Company","keywords":"Topiramate; Migraine; Medicine; Discontinuation; Tolerability; Placebo; Meta-analysis; Randomized controlled trial; Relative risk; Adverse effect; Internal medicine; Confidence interval; Anesthesia; Psychiatry; Epilepsy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01349825,0.0003478175,0.003815631,0.0005197046,0.0001188026,0.00005854318,0.0001222329,0.0001430483,0.00005859068],"category_scores_gemma":[0.001185089,0.0001896542,0.001401172,0.0006703644,0.0001821805,0.0001401738,0.00008082553,0.0006817835,0.000002152249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002086385,"about_ca_system_score_gemma":0.0001351974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001384414,"about_ca_topic_score_gemma":0.0005843645,"domain_scores_codex":[0.9940497,0.003411845,0.001637545,0.0002184323,0.0004259771,0.0002564944],"domain_scores_gemma":[0.9965504,0.002218706,0.0006450415,0.0002715126,0.0001870883,0.0001272989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0008324527,0.001327285,0.0004838814,0.06315047,0.3886223,0.0003920621,0.01915085,0.00001342752,0.00002945101,0.001578055,0.07052737,0.4538924],"study_design_scores_gemma":[0.0005391592,0.0009701788,0.0004315884,0.002943085,0.5394199,0.0002385786,0.002311023,0.00009945728,0.000001818043,0.0001766511,0.452592,0.0002765793],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007010734,0.9935018,0.00008602927,0.005003503,0.00001738594,0.0004072609,0.00001698566,0.000009737449,0.0002561806],"genre_scores_gemma":[0.002487989,0.9949148,0.0002127852,0.0002605772,0.0001618473,0.000009590258,0.0000430197,0.00003644781,0.001872999],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4536158,"threshold_uncertainty_score":0.7733873,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2547492849517618,"score_gpt":0.4521236143070481,"score_spread":0.1973743293552863,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}